Clinical value of whole-blood interferon-gamma assay in patients with suspected pulmonary tuberculosis and AFB smear- and polymerase chain reaction-negative bronchial aspirates

Diagn Microbiol Infect Dis. 2012 Jul;73(3):252-6. doi: 10.1016/j.diagmicrobio.2012.03.019. Epub 2012 Apr 26.

Abstract

Combining a polymerase chain reaction (PCR) test with bronchoscopy is frequently performed to allow a rapid diagnosis of smear-negative pulmonary tuberculosis (PTB). However, limited data are available concerning clinical judgment in patients with suspected PTB and AFB smear- and PCR-negative bronchial aspirates (BA). The present study evaluated the usefulness of whole-blood QuantiFERON-TB Gold In-Tube (QFT) testing in these patients. Of 166 patients with suspected PTB who had undergone bronchoscopy because of smear-negative sputum or inadequate sputum production, 93 (56%) were diagnosed with culture-positive PTB. Seventy-four patients were either AFB smear- or PCR-positive. In the 75 patients whose BA AFB smear and PCR results were both negative, 19 were finally diagnosed with PTB by culture. The QFT test had a negative predictive value of 91% for PTB. The QFT test may be useful for excluding PTB in patients with suspected PTB whose BA AFB smear and PCR results are both negative.

Publication types

  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bacteriological Techniques / methods*
  • Blood / immunology*
  • Bronchi / microbiology
  • Exudates and Transudates / microbiology
  • Female
  • Humans
  • Interferon-gamma Release Tests / methods*
  • Male
  • Microscopy / methods
  • Middle Aged
  • Polymerase Chain Reaction / methods
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Sputum / microbiology
  • Tuberculosis, Pulmonary / diagnosis*
  • Young Adult